Anthony J. Pateman
GlaxoSmithKline (United Kingdom)(GB)
Publications by Year
Research Areas
Blood Coagulation and Thrombosis Mechanisms, Atrial Fibrillation Management and Outcomes, Cardiac electrophysiology and arrhythmias, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Antifungal resistance and susceptibility
Most-Cited Works
- → Factor Xa Inhibitors: S1 Binding Interactions of a Series of N-{(3S)-1-[(1S)-1-Methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}sulfonamides(2007)49 cited
- → Structure- and property-based design of factor Xa inhibitors: Pyrrolidin-2-ones with acyclic alanyl amides as P4 motifs(2006)40 cited
- → Structure and property based design of factor Xa inhibitors: Pyrrolidin-2-ones with biaryl P4 motifs(2007)29 cited
- → A sensitive radioimmunoassay, incorporating solid-phase extraction, for fluticasone 17-propionate in plasma(1993)25 cited
- → Structure and property based design of factor Xa inhibitors: Biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifs(2007)23 cited
- → The determination of nicotinic acid in plasma by mixed-mode liquid chromatography–tandem mass spectrometry following ion exchange solid phase extraction(2006)22 cited
- → Selective and dual action orally active inhibitors of thrombin and factor Xa(2007)22 cited
- → Antithrombotic Potential of GW813893: A Novel, Orally Active, Active-site Directed Factor Xa Inhibitor(2008)17 cited
- → The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs(2011)13 cited
- → Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with monoaryl P4 motifs(2009)12 cited